Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.314 SEK | -1.88% | +3.97% | -3.98% |
05-20 | Spago Nanomedical Provides an Update on Tumorad-01, Trial Proceeds as Planned | CI |
05-02 | Spago Nanomedical AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
- Stock Market
- Equities
- SPAG Stock
- News Spago Nanomedical AB